Monthly Archives: March 2020

Iren SpA to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Iren SpA (OTCMKTS:IRDEF) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60932

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 582417

Viela Bio Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Viela Bio Inc (NASDAQ:VIE) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60854

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 582416

Personalis Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Personalis Inc (NASDAQ:PSNL) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60757

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 582414

Azrieli Group Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Azrieli Group Ltd. (OTCMKTS:AZZRY) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60811

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 582413

Findit Featured Member Carolina Pool Consultants Offers Free Concrete Pool Estimates Across Greater Denver North Carolina

ATLANTA, GA / ACCESSWIRE / March 25, 2020 / Findit®, Inc. (OTC PINK:FDIT) owner of Findit.com®, a full service social networking management platform that provides a full line of marketing services, is featuring Findit member Carolina Pool Consultants, who is a professional year round pool builder that designs, builds and installs beautiful concrete pools across Greater Denver NC, including Newton, Iron Station, Terrell, Lincolnton and Sherrills Ford.

Carolina Pool Consultants is a professional concrete pool builder in Denver NC They design, build and install concrete pools for customers across the Greater NC Area. While homeowners have a choice between fiberglass pools, vinyl liner pools, and concrete pools, homeowners most often go with concrete when CPC Pools goes over with them the advantages that concrete pools have over the other two. CPC Pools offers free in home pool estimates and 3D pool renderings so homeowners know exactly what they can expect when they move forward with their decision to get a brand new pool built in their backyard by Carolina Pool Consultants.

https://www.youtube.com/watch?v=o9suPjER_VE

Findit has been providing online marketing services to Carolina Pool Consultants since March for 2017. The services Findit® provides Carolina Pool Consultants includes content creation and social network marketing to increase the overall online presence of Carolina Pool Consultants in search engines and on social networking sites. The content is created within Carolina Pool Consultant's Findit sites that they claimed utilizing Findit's Claim your Name Tool To date, Carolina Pool Consultants has claimed 18 Findit Names. The Findit Names are based off of specific towns that CPC Pools serves along with the type of service that they provide. The purpose of these Findit Sites is to increase overall online exposure and increase the number of search results in search engines that Carolina Pool Consultants has under the town and service that they provide pool building services in.

https://www.youtube.com/watch?v=4XcHFZ43qLk

Visit Carolina Pool Consultants Under Some Of Their Findit Names

findit.com/inground-concrete-pool-builder-sherrills-ford

findit.com/newton-conover-inground-conrete-pool-builder

findit.com/inground-concrete-pool-builder-terrell-nc

findit.com/inground-concrete-pools-installed-lincolnton-nc

findit.com/inground-concrete-pool-builder-iron-station-nc

findit.com/inground-concrete-pools-installed-denver-nc

Check Out Some of CPC Pools Latest Findit Posts

Lincolnton North Carolina Concrete Pool Installer

Get In Touch with The Best Concrete Pool Builder in Iron Station

Speak with the Best Denver NC Concrete Pool Builders

Home owners can schedule a free in home pool consultation with Carolina Pool Consultants today at 704-799-5236, tell them Findit sent you. Visit Carolina Pool Consultants online at mycpcpools.com

Pool builders that are seeking the same tangible online results that Carolina Poll Consultants has achieved with Findit can call Findit for a free quote at 404-443-3224.

About Carolina Pool Consultants

https://www.youtube.com/watch?v=_WWa9cCX7_g

Carolina Pool Consultants is not a multi-national, conglomerate corporation. Nor do we plan on building thousands of pools per year. In the eyes of those other Charlotte-area pool builders, their own customers are just numbers on a paycheck.

We're CPC Pools, and we make pools great again. Our goal is to dominate the production chain so the customer gets their pool done right the first time, in record time, every time. We can proudly say we do most all of the major steps in-house with the exception of steps which require vetted, licensed tradesmen (plumbing, electrical, etc.) The results are disruptive to the industry. No longer does the consumer have to worry about which company did what. No longer does the scheduler live at the mercy of the subcontractors' daily agenda. No longer are there lapses in accountability. It's simple. It's honest. It's how pool building should be.

About Findit, Inc.

Findit, Inc., owns Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTCPinksheets.

Safe Harbor:

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.

CONTACT:

Clark St. Amant
404-443-3224

SOURCE: Findit, Inc.

ReleaseID: 582514

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tupperware Brands Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tupperware Brands Corporation ("Tupperware" or "the Company") (NYSE:TUP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between January 30, 2019 and February 24, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before April 27, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Tupperware failed to maintain appropriate internal controls. Based on this failure, the Company was forced to investigate the accounting and liabilities of its Fuller Mexico division. Due to this investigation, the Company delayed the filing of its annual report on Form 10-K for fiscal year 2019. The Company did not properly account for Fuller Mexico's accounts payable and accrued liabilities, resulting in it overvaluing its earnings per share guidance. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Tupperware, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 582545

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against World Wrestling Entertainment, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against World Wrestling Entertainment, Inc. ("WWE" or "the Company") (NYSE:WWE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 7, 2019 and February 5, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before May 5, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. WWE suffered from increasing tensions with the government of Saudi Arabia including a breakdown of negotiations over the renewal of its broadcasting distribution deal. The Saudi government failed to make payments to the Company number in the millions of dollars. One such payment for a June 2019 event amounted to $60 million. Orbit Showcase Network ("OSN") terminated WWE broadcasts in the first quarter of 2019, despite its contractual obligations to continue. OSN's actions, along with rebuffing renewal efforts, made the likelihood of a renewal in 2019 or the future very small. WWE lacked the capacity to expand its operations in the Middle East or within Saudi Arabia, despite what it had promised investors. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about WWE, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 582543

SHAREHOLDER ALERT: WBK BDX XP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Westpac Banking Corporation (NYSE:WBK)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/westpac-banking-corporation-loss-submission-form?prid=5805&wire=1
Lead Plaintiff Deadline: March 30, 2020
Class Period: November 11, 2015 to November 19, 2019

Allegations against WBK include that: (1) contrary to Australian law, the Company failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre ("AUSTRAC"); (2) the Company did not appropriately monitor and assess the ongoing money laundering and terrorism financing risks associated with movement of money into and out of Australia; (3) the Westpac did not pass on requisite information about the source of funds to other banks in the transfer chain; (4) despite being aware of the heightened risks, the Company did not carry out appropriate due diligence on transactions in South East Asia and the Philippines that had known financial indicators relating to child exploitation risks; (5) the Company's Anti-Money Laundering and Counter-Terrorism Financing Policy Program was inadequate to identify, mitigate and manage money laundering and terrorism financing risks; and (6) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Becton Dickinson & Company (NYSE:BDX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/becton-dickinson-company-loss-submission-form?prid=5805&wire=1
Lead Plaintiff Deadline: April 27, 2020
Class Period: November 5, 2019 to February 5, 2020

Allegations against BDX include that: (1) certain of Becton's Alaris infusion pumps experienced software errors and alarm prioritization issues; (2) as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to "make enhancements;" (3) the Company was reasonably likely to face regulatory delays in connection with the software remediation; (4) as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

XP Inc. (NASDAQ:XP)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/xp-inc-loss-submission-form?prid=5805&wire=1
Lead Plaintiff Deadline: May 20, 2020
Class Period: or otherwise acquired XP's securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with XP's December 2019 initial public offering.

Allegations against XP include that: (1) XP engaged in undisclosed related party transactions; (2) XP failed to disclose its common and large system failures and connected losses; (3) XP's aggressive IFA strategy was and is tenuous; (4) XP had material weaknesses; (5) XP fired its previous accounting firm due to that firm finding and disclosing material weaknesses; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 582542

NeuroRx to discuss investigational drug for COVID-19 related Acute Respiratory Distress at Solebury Trout Virtual Global Healthcare Conference on March 26, 2020

NeuroRx is leading US development of RLF-100 (Aviptadil) on behalf of Relief Therapeutics' (RLF)

WILMINGTON, DE and RADNOR, PA / ACCESSWIRE / March 25, 2020 / NeuroRx, a clinical stage biopharma company focused on development of CNS drugs, today announced an expansion of scope to include the co-development of a potentially lifesaving drug for COVID-related Acute Respiratory Distress Syndrome (ARDS). Aviptadil (RLF-100) is a synthetic form of Vasoactive Inhibitory Polypeptide, developed by Relief Therapeutics of Geneva, Switzerland.

Because of the enormous focus in the military and veterans community on suicidal depression and PTSD, NeuroRx assembled a board that included senior military and policy leaders. Our previous experience in national health security policy made the collaboration with Relief around development of its promising asset a natural partnership.

Deaths associated with COVID-19 are primarily caused by ARDS in which the intense cytokine (inflammatory storm) unleashed in the lung makes it impossible for the lung to transmit oxygen, even with mechanical ventilation, said Jonathan Javitt, M.D., M.P.H., Chief Executive Officer of NeuroRx, who has also been named Vice Chair of Relief Therapeutics. RLF-100 demonstrated important phase 1 proof of concept data and was awarded orphan drug designation for ARDS in 2005 at a time when the average American had never heard of ARDS. Today, ARDS has become a critical national priority.

Solebury Trout Virtual Global Healthcare Conference
Date: March 26, 2020
Time: 2:00pm Eastern Time
Location: Access Link

Corona-Virus (COVID-19) death is primarily caused by Acute Respiratory Distress Syndrome (ARDS), in which severe inflammation causes the lungs to fill with fluid and is associated with 50% mortality.
RLF-100 (Aviptadil) from RELIEF THERAPEUTICS has shown clinical benefit in phase 1/2 trials of pulmonary arterial hypertension, sarcoidosis, and ARDS.
Relief is initiating phase 2 proof-of-concept trials studies to treat ARDS in COVID-19 patients who otherwise have less than a 50% chance of survival.
More information on clinicaltrials.gov

About RLF-100 (Aviptadil)

RLF-100 (Aviptadil) is a patented formulation of Vasoactive Intestinal Polypeptide (VIP) that was originally developed and is currently marketed in Europe for the treatment of erectile dysfunction. VIP is known to be highly concentrated in the lung and to inhibit a variety of inflammatory cytokines. Aviptadil was awarded Orphan Drug Designation in 2001 by the US FDA for treatment of Acute Respiratory Distress Syndrome and in 2005 for treatment of Pulmonary Arterial Hypertension. Aviptadil was awarded Orphan Drug Designation by the European Medicines Agency in 2006 for the treatment of Acute Lung Injury and in 2007 for the treatment of Sarcoidosis. Both the US FDA and the EMEA have granted Investigational New Drug licenses for human phase 2 trials of Aviptadil. Aviptadil is Vasoactive Intestinal Polypeptide (VIP), a naturally-occurring peptide hormone that is known to be concentrated in the lungs. VIP has been shown in five species of animal models to have potent effect in models of ARDS and Acute Lung Injury. In these models, Aviptadil has shown potent anti-inflammatory and specifically anti-cytokine activity in the lungs.

About NeuroRx, Inc.

NeuroRx draws upon 30 years of basic science and clinical expertise in the role of N- methyl-D- aspartate (NMDA), a receptor that regulates human thought processes, particularly depression and suicidality and is now shown to play a role in the pathogenesis of ARDS. The company is privately funded and led by former senior executives of Johnson & Johnson, BMS, Eli Lilly, and Pfizer. NeuroRx's Board of Directors and Advisors includes Hon. Sherry Glied, former Assistant Secretary, U.S. Dept. of Health and Human Services; Mr. Chaim Hurvitz, former President of the Teva International Group, Lt. Gen. HR McMaster, the 23rd National Security Advisor, Wayne Pines, former Associate Commissioner of the U.S. Food and Drug Administration, Judge Abraham Sofaer, and Daniel Troy, former Chief Counsel, U.S. Food and Drug Administration.

Learn more at www.Neurorxpharma.com

For further information, please contact:

Investor Contact:

Brian Korb
Solebury Trout
+1-646-378-2923
bkorb@soleburytrout.com

SOURCE: NeuroRx

ReleaseID: 582541

RTIX INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies RTI Surgical Holdings, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against of RTI Surgical Holdings, Inc. ("RTI" or the Company") (NASDAQ:RTIX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired RTI securities March 7, 2016 and March 16, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/rtix.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statementsthat: (1) the Company inappropriately recognized revenues with respect to certain contractual arrangements, including other equipment manufacturer customers; (2) the Company's internal controls over financial reporting were not effective; (3) as a result, the Company would be forced to delay the filing of its Form 10-K for fiscal year ended December 31, 2019; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/rtix or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in RTI you have until May 22, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 582539